Open AccessPredictive Factors of Eribulin Activity in Metastatic Breast Cancer Patients
Author(s) -
Rita De Sanctis,
Elisa Agostinetto,
Giovanna Masci,
Emanuela Ferraro,
Agnese Losurdo,
Alessandro Viganò,
Lidija Antunovic,
Monica Zuradelli,
Rosalba Torrisi,
Armando Santoro
Publication year - 2018
Publication title -
oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.987
H-Index - 98
eISSN - 1423-0232
pISSN - 0030-2414
DOI - 10.1159/000489065
Subject(s) - eribulin , medicine , metastatic breast cancer , oncology , proportional hazards model , breast cancer , cancer
Predictive factors of response to eribulin are lacking. We aimed to investigate the activity and safety of eribulin in a real-world population of metastatic breast cancer (MBC) patients and to identify possible predictive factors of progression-free survival (PFS) and objective response.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom